Gene · 54880
Papers3,332
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
421 to 440 of 3,332
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Osteosarcoma's genetic landscape painted by genes' mutations. | Acta Biochim Pol | 2023 | 37717265 | PubTator, text mining | PubMed |
| Genomic characterization of thymic epithelial tumors in a real-world dataset. | ESMO Open | 2023 | 37703595 | PubTator, text mining | PubMed |
| Surgical management of primary gastric Ewing-like sarcoma at the lesser curvature. | J Surg Case Rep | 2023 | 37701447 | PubTator, text mining | PubMed |
| A Novel RUNX1 Genetic Variant Identified in a Young Male with Severe Osteoporosis. | JBMR Plus | 2023 | 37701147 | PubTator, text mining | PubMed |
| Expanding the Clinical Utility of Targeted RNA Sequencing Panels beyond Gene Fusions to Complex, Intragenic Structural Rearrangements. | Cancers (Basel) | 2023 | 37686670 | PubTator, text mining | PubMed |
| Management and Molecular Characterization of Intraventricular Glioblastoma: A Single-Institution Case Series. | Int J Mol Sci | 2023 | 37686092 | PubTator, text mining | PubMed |
| Vacuolar ATPase Is a Possible Therapeutic Target in Acute Myeloid Leukemia: Focus on Patient Heterogeneity and Treatment Toxicity. | J Clin Med | 2023 | 37685612 | PubTator, text mining | PubMed |
| Potential value of high-throughput single-cell DNA sequencing of Juvenile myelomonocytic leukemia: report of two cases. | NPJ Syst Biol Appl | 2023 | 37684264 | PubTator, text mining | PubMed |
| Secondary-type mutations do not impact outcome in NPM1-mutated acute myeloid leukemia - implications for the European LeukemiaNet risk classification. | Leukemia | 2023 | 37679502 | PubTator, text mining | PubMed |
| Somatic mutations of thymic epithelial tumors with myasthenia gravis. | Front Oncol | 2023 | 37671056 | PubTator, text mining | PubMed |
| The molecular profile in patients with polycythemia vera and essential thrombocythemia is dynamic and correlates with disease's phenotype. | Front Oncol | 2023 | 37671053 | PubTator, text mining | PubMed |
| Gemtuzumab ozogamicin plus standard induction hemotherapy improves outcomes of newly diagnosed intermediate cytogenetic risk acute myeloid leukemia. | Blood Cancer J | 2023 | 37666807 | PubTator, text mining | PubMed |
| A review of the therapeutic potential of histone deacetylase inhibitors in rhabdomyosarcoma. | Front Oncol | 2023 | 37664028 | PubTator, text mining | PubMed |
| FUS-ERG induces late-onset azacitidine resistance in acute myeloid leukaemia cells. | Sci Rep | 2023 | 37660196 | PubTator, text mining | PubMed |
| Genetics in ophthalmology: molecular blueprints of retinoblastoma. | Hum Genomics | 2023 | 37658463 | PubTator, text mining | PubMed |
| The many faces of nodal and splenic marginal zone lymphomas. A report of the 2022 EA4HP/SH lymphoma workshop. | Virchows Arch | 2023 | 37656249 | PubTator, text mining | PubMed |
| Extra-skeletal Ewing's sarcoma of the leg with multiple skeletal and pulmonary metastases: A rare pediatric case report. | SAGE Open Med Case Rep | 2023 | 37654555 | PubTator, text mining | PubMed |
| Development and validation of educational multimedia to promote public health literacy about healthy cognitive aging. | Health Expect | 2023 | 37635370 | PubTator, text mining | PubMed |
| KDM2B-Rearranged Soft Tissue Sarcomas Expand the Concept of BCOR-Associated Sarcoma. | Mod Pathol | 2023 | 37634866 | PubTator, text mining | PubMed |
| A Nine-Gene Expression Signature Distinguished a Patient with Chronic Lymphocytic Leukemia Who Underwent Prolonged Periodic Fasting. | Medicina (Kaunas) | 2023 | 37629695 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54880/papers?page=22